Skip to main navigation Skip to search Skip to main content

Irit Avivi

Professor

Former affiliation
1994 …2026

Research activity per year

Fingerprint

Dive into the research topics where Irit Avivi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • Open Access
    1 Scopus citations
  • Can Belantamab mafodotin cause macro LDH?

    Hakakian, L., Shragai, T., Trestman, S., Cohen, Y. C., Katz, B. Z., Arafat, N., Hassoun, E., Melamed, N. & Avivi, I., 2026, (Accepted/In press) In: Leukemia and Lymphoma.

    Research output: Contribution to journalArticlepeer-review

  • Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

    Falchi, L., Nijland, M., Huang, H., Linton, K. M., Seymour, J. F., Tao, R., Kwiatek, M., Costa, A., Vassilakopoulos, T. P., Greil, R., Jiménez-Ubieto, A., Gangatharan, S. A., Benjamini, O., Thieblemont, C., Tucci, A., Elinder-Camburn, A., Illes, A., Novak, J., Pavlovsky, M. A. & McDonald, A. & 178 others, Yoon, D. H., Maruyama, D., Sunkersett, G., Mei, J. P., Mukherjee, N., Zhu, F., Alshreef, A., Favaro, E., Morschhauser, F., Tsirigotis, P., Pereira, J., Gonzalez de Villambrosia, S., Schmidt Filho, J., Avivi, I., Jurczak, W., Casasnovas, O., Miguel Bergua Burgues, J., Shen, J., Goldschmidt, N., Bouzani, M., Nagy, Z., Ysebaert, L., Houot, R., Tessoulin, B., Laurent Damaj, G., Vitolo, U., Manuel Sancho, J., Vanguru, V., Yeh, S. P., Yan, X., Freeman, A., Larouche, J. F., Modok, S., Patti, C., Sanchez Garcia, J., Roberto de Mattos, E., Walker, P., Ok Lee, J., Fukuhara, S., Mishima, Y., Jin, J., Qian, Z., Sterrett, R., Gurion, R., Rotter, N., Belada, D., Kopeckova, K., Trneny, M., Bouabdallah, K., LeBras, L., Waultier, A., Guidez, S., Feugier, P., Derenzini, E., Margiotta Casaluci, G., Sanchez Gonzalez, B., Lopez Jiménez, J., Gutierrez Gutierrez, N., Rodriguez, G., Carolina Caballero Gonzalez, A., de Jongh, E., Terpstra, W., Vermaat, J., Chen, T. Y., Liu, H. L., Ikezoe, T., Wu, H., Li, W., Jing, H., Kittai, A., Diefenbach, C., Hunter, B., Horowitz, N., Pichler, P., Mikala, G., Masszi, A., Drgona, L., Ngirabacu, M. C., Janssens, A., Guieze, R., Durot, E., Haioun, C., Duell, J., Schalk, E., Tani, M., Carla Oliveira Ramos, A., Cordoba Mascunano, R., Grande Garcia, C., de la Fuente, A., Roost Clausen, M., Thomsen, T., Lagerlof, I., Nijhof, I., Johnson, R., Leao Cordeiro de, D., Bigni, R., Choong Lai, H., Issa, S., Shin, D. Y., Chou, C. W., Goto, H., Nakao, T., Li, C., Wei, X., Wei, X., Qian, W., Ma, S., Donthireddy, V., Diefenbach, C., Fesler, M., Hernandez-Ilizaliturri, F., Levy, M., Kumar, A., Yimer, H., Berz, D., Cabanillas, F., Koren Michowitz, M., Ozcan, M., Salim, O., Saydam, G., Turgut, M., Mehtap, O., Orhan Ayyildiz, M., Katodritou, E., Dimopoulos, M. A., Rajnics, P., Van Hende, V., Roufosse, R., Vrelust, I., Morineau, N., Choquet, S., Bachy, E., Abraham, J., Kroschinsky, F., Herling, C., Ladetto, M., Scalzulli, P., Ferreri, A., Ferrero, S., Hohaus, S., Kallert, S., Johansson, B., Boersma, R., Libourel, E., Klerk, C., Wilson, M., Auer, R., Paneesha, S., Eyre, T., Lewis, D., Ayto, R., Osborne, W., Andrea Guanchiale, L., Chuah, H., Shetty, A., Cheah, C., Kilfoyle, A., Seog Kim, W., Shin, H. J., Fujisaki, T., Kumode, T., Ishitsuka, K., Yuda, J., Yokoyama, H., Kato, K., Kitawaki, T., Kondo, T., Suehiro, Y., Ogawa, Y., Nakazawa, H., Tomita, A., Kamata, H., Lai, X., Shuang, Y., Gao, G., Liu, L., Yang, H. & Cen, X. N., 10 Jan 2026, In: The Lancet. 407, 10524, p. 161-173 13 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    6 Scopus citations
  • Histologic Transformation in Follicular Lymphoma: Real-World Outcomes with Rituximab vs. Obinutuzumab-Based Combinations

    Shpitzer, D., Perry, C., Shragai, T., Melamed, G., Smith, M. R., Vitkon, R., Alapi, H. & Avivi, I., May 2026, In: Cancers. 18, 9, 1471.

    Research output: Contribution to journalArticlepeer-review

    Open Access
  • Safety and Efficacy of Talquetamab + Teclistamab In Patients with Relapsed/Refractory Multiple Myeloma from Phase 1B of Redirectt-1: Results with an Extended Median Follow-Up of 3 Years

    Ocio, E. M., Mateos, M. V., Magen, H., Gatt, M., Sebag, M., Kim, K., Min, C. K., Yoon, S. S., Chu, M. P., Rodríguez-Otero, P., Avivi, I., Cardé, N. A. Q., Krevvata, M., Henninger, T., Thakkar, P., Festa, M., Huang, L., Zhou, J. X., Takamoto, M. & Pei, L. & 6 others, Lu, J., Maffucci, C., Scott, E., Oriol, A., Morillo, D. & Cohen, Y. C., Jan 2026, In: Haematologica. 111, p. 38 1 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access